Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Friday, August 31, 2018

House Messages CMS: Asks CMS to Address Panel Unbundling

›
Each year, annual budgets prepared at House and Senate come with something called "report language" which describes something of t...

MolDx Releases Set of New LCDs

›
A Genomeweb article on August 30, 2018, notes that MolDx has released a draft LCD favorable to the Veracyte test Envisia, for pulmonary fibr...
Thursday, August 30, 2018

Very Brief Blog: The Swing to FDA Approval: FMI Discontinues F1 Test for CDx Test

›
I may not be the first one to hear it but I heard today:  Foundation Medicine is officially turning off the production line on its F1 test. ...
Wednesday, August 29, 2018

Very Brief Blog: MolDx Analysis of Evidence "Quality, Strength, and Weight"

›
The 21st Century Cures Act requires LCDs to provide rationales for their decisions and a summary of evidence considered .   For an overview...

Very Brief Blog: New Medical Director at CMS MolDx Program - Dr Paul Gerrard

›
The Medicare special contractor program for genomic tests, MolDx , has a new interim medical director, Dr. Paul Gerrard.   Labs who work wit...
Wednesday, August 22, 2018

My Short Deck on LCD/NCD and Combination Diagnostics: For NextGenDx Conference in DC

›
This week is the 1000-person NextGenerationDx conference in Washington, here . This afternoon I have the chance to present a concise 15-mi...
Monday, August 20, 2018

Two New Research Studies Propose Updated Approaches to Medicare Dx LCDs

›
Classically, a new diagnostic test is created and its developer produces a series of studies showing it is clinically valid and has strong c...
Saturday, August 18, 2018

Two Precision Medicine-Related Conferences in Nashvillle, September/October 2018

›
Two precision medicine related conferences in Nashville in September and October 2018. The first is sponsored by the "Precision Medic...

Foundation Medicine's Final SEC Report: Medicare Policy as a Chutes and Ladders Game

›
On August 9, 2018, Foundation Medicine (FMI) filed its SEC 10-Q  [MAY NOT WORK; SEE CLOUD COPY INFRA] for the quarter ending June 30. And on...
Friday, August 17, 2018

Brief Blog: CAP Keeps Legislative LCD Reform Alive

›
In its July 31, 2018, open access government affairs bulletin STATLINE, College of American Pathologists notes that its legislation to impro...
Thursday, August 16, 2018

FDALawBlog posts FDA's 59-page Diagnostics Legislation for Reform of Itself

›
Update 2019/07.   This blog leads to the 59 page FDA comments on DAIA in 8/2018.  See a July 2019 blog that leads to 18 page HHS comments o...
Wednesday, August 15, 2018

Very Brief Blog: Legislation Would Cover Know-Error DNA Biopsy Provenance Test; Not Covered by MACs

›
In a brief tidbit, the MolDx program does not cover the Know Error Test, a DNA test that confirms the provenance (origin) of biopsy specimen...

President's 2019 Budget Proposes Cutting USPSTF Budget

›
I ran across the President's 2019 Proposed Budget for AHRQ, which includes a discussion of the sub-budget for U.S. Preventive Services T...

MolDx Program Drops "Coverage with Data Development" From Its Handbook

›
National CED Coverage with Evidence Development (CED) is a form of gated entry for new technologies into the healthcare payment system.*  ...
Thursday, August 9, 2018

California MD-PhD Becomes Head of Diagnostics at FDA: Tim Stenzel

›
Amidst a significant reorganization of the Center for Devices and Radiologic Health (CDRH), Tim Stenzel MD PhD becomes head of the Office of...
‹
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.